KAYO MOTOR
834058
Zhejiang Zoenn Design
300901
Zhejiang Meorient Commerce & Exhibition Inc.
300795
Fujian Zitian Media Technology
300280
Zhejiang Prulde Electric Appliance
301353
CN Stock MarketDetailed Quotes
300529 Jafron Biomedical
- 30.17
- -0.51-1.66%
Market Closed Dec 13 15:00 CST
24.09BMarket Cap29.96P/E (TTM)
30.68High29.89Low71.70KlotVolume30.68Open30.68Pre Close215.95MTurnover1.40%Turnover Ratio55.16P/E (Static)798.61MShares39.2452wk High7.60P/B15.46BFloat Cap15.5052wk Low36.82Limit Up512.49MShs Float101.06Historical High24.54Limit Down2.58%Amplitude3.15Historical Low0.40Dividend TTM30.12Avg Price42.69KlotAsk1.33%Div YieldTTM100Lot Size25.46KlotBid
Jafron Biomedical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 30.04%2.31B | 36.11%1.66B | 44.68%878.54M | -18.60%2.37B | -17.77%1.78B | -17.25%1.22B | -10.14%607.21M | 0.30%2.91B | 17.24%2.16B | 19.72%1.47B |
| Refunds of taxes and levies | -40.22%1.43M | -45.29%1.19M | -69.21%428.15K | -79.19%2.4M | -77.97%2.39M | -77.44%2.17M | 453.98%1.39M | 2,304.71%11.55M | 3,001.52%10.84M | 20,711.73%9.63M |
| Cash received relating to other operating activities | -48.85%56.84M | -32.02%45.57M | 2.89%23.7M | 4.72%153.4M | 52.88%111.13M | 4.99%67.03M | 172.02%23.04M | -14.55%146.49M | -30.76%72.69M | -23.55%63.85M |
| Cash inflows from operating activities | 25.31%2.37B | 32.42%1.7B | 42.91%902.68M | -17.71%2.52B | -15.77%1.89B | -16.71%1.29B | -7.72%631.64M | -0.17%3.07B | 15.18%2.24B | 17.70%1.54B |
| Goods services cash paid | -8.80%281.61M | -3.39%162.6M | -10.15%71.27M | -43.56%318.42M | -35.43%308.78M | -41.90%168.31M | -51.30%79.32M | 20.12%564.2M | 60.31%478.19M | 51.46%289.71M |
| Staff behalf paid | 3.29%451.8M | -1.52%308.86M | -11.92%114.03M | -17.11%570.81M | -10.60%437.41M | -5.53%313.61M | 4.94%129.46M | 40.39%688.62M | 41.88%489.25M | 43.67%331.99M |
| All taxes paid | 91.94%357.96M | 88.21%228.48M | 11.09%88.15M | -43.12%257.94M | -53.34%186.49M | -49.65%121.4M | -47.60%79.35M | 5.93%453.49M | 25.59%399.71M | 21.34%241.1M |
| Cash paid relating to other operating activities | 10.33%403.58M | 3.12%253.51M | 17.15%122.13M | -3.55%459.58M | 4.55%365.81M | 5.79%245.84M | -12.20%104.25M | 9.81%476.51M | 9.67%349.9M | 17.16%232.38M |
| Cash outflows from operating activities | 15.13%1.49B | 12.28%953.46M | 0.82%395.58M | -26.39%1.61B | -24.38%1.3B | -22.46%849.17M | -29.48%392.38M | 19.79%2.18B | 34.10%1.72B | 33.65%1.1B |
| Net cash flows from operating activities | 47.72%871.6M | 71.58%749.27M | 111.94%507.1M | 3.73%916.74M | 12.37%590.04M | -2.67%436.7M | 86.83%239.26M | -29.26%883.8M | -21.17%525.09M | -8.87%448.67M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | --1.55B | --1.03B | --422M | ---- | --0 | ---- | ---- | -49.84%2.2B | -9.01%2.1B | 12.67%1.8B |
| Cash received from returns on investments | --24.46M | --8.18M | --2.53M | ---- | --0 | ---- | ---- | -63.34%10.52M | -41.49%10.48M | -22.32%9.66M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -59.33%4.89M | -99.25%69.83K | -99.14%69.03K | 82.51%12.6M | 6,418.83%12.02M | 4,930.87%9.28M | 4,384.80%8.02M | 599.46%6.91M | -83.80%184.4K | -78.32%184.4K |
| Cash inflows from investing activities | 12,997.70%1.57B | 11,091.74%1.04B | 5,192.05%424.6M | -99.43%12.6M | -99.43%12.02M | -99.49%9.28M | -99.56%8.02M | -49.78%2.22B | -9.30%2.11B | 12.35%1.81B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 77.76%179.48M | 76.59%128.1M | 170.66%95.87M | -48.04%247.25M | -75.84%100.96M | -74.62%72.54M | -75.77%35.42M | -11.45%475.89M | -4.08%417.89M | -0.59%285.87M |
| Cash paid to acquire investments | --3.57B | --2.03B | --1.17B | -99.27%15M | --0 | ---- | ---- | -54.98%2.05B | -39.51%1.95B | 2.33%1.65B |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --184.02K | ---- | ---- |
| Cash outflows from investing activities | 3,616.42%3.75B | 2,868.76%2.15B | 3,468.27%1.26B | -89.62%262.25M | -95.74%100.96M | -96.25%72.54M | -98.03%35.42M | -50.38%2.53B | -35.29%2.37B | 1.89%1.94B |
| Net cash flows from investing activities | -2,348.52%-2.18B | -1,662.98%-1.12B | -2,963.44%-839.27M | 18.39%-249.65M | 65.05%-88.94M | 48.69%-63.27M | -257.25%-27.4M | 54.36%-305.9M | 80.85%-254.49M | 57.01%-123.29M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --0 | ---- | ---- | -99.81%128.11K | --128.11K | --128.11K | --128.11K | -65.51%67.29M | ---- | ---- |
| Cash from borrowing | -60.04%294.43M | -41.27%262.16M | -23.37%251.83M | 157.47%762.92M | 332.91%736.78M | --446.37M | --328.63M | --296.32M | --170.19M | ---- |
| Cash received relating to other financing activities | -60.79%50M | -61.44%50M | ---- | 1,063.62%130.17M | 1,262.90%127.51M | 1,875.51%129.66M | -87.37%437.77K | 25.08%11.19M | 3,253.97%9.36M | -32.78%6.56M |
| Cash inflows from financing activities | -60.15%344.43M | -45.82%312.16M | -23.50%251.83M | 138.32%893.21M | 381.44%864.41M | 8,678.58%576.16M | 9,396.94%329.2M | -68.83%374.79M | -84.95%179.55M | -99.45%6.56M |
| Borrowing repayment | 39.21%364.16M | 12,637.81%254.76M | --126.5M | --344.5M | --261.59M | --2M | ---- | ---- | ---- | ---- |
| Dividend interest payment | -40.02%334.67M | -40.03%330.44M | 7.86%5.53M | -22.98%561.79M | -22.51%557.94M | -23.47%550.99M | --5.13M | 37.36%729.42M | 35.59%720M | 35.59%719.99M |
| Cash payments relating to other financing activities | -2.76%373.29M | 44.74%373.29M | --213M | 3,783.19%438.84M | 7,293.43%383.87M | --257.91M | ---- | -97.77%11.3M | -98.21%5.19M | ---- |
| Cash outflows from financing activities | -10.91%1.07B | 18.20%958.49M | 6,628.19%345.04M | 81.60%1.35B | 65.94%1.2B | 12.63%810.89M | --5.13M | -28.58%740.72M | -11.73%725.19M | 35.59%719.99M |
| Net cash flows from financing activities | -114.67%-727.69M | -175.35%-646.33M | -128.76%-93.21M | -23.50%-451.91M | 37.87%-338.98M | 67.10%-234.73M | 9,249.00%324.07M | -321.54%-365.93M | -247.04%-545.64M | -208.59%-713.42M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -4,146.55%-787.74K | 428.53%95.71K | 78.47%-48.88K | 131.31%11.39K | -101.49%-18.55K | -104.43%-29.13K | -751.92%-226.98K | -756,607.69%-36.4K | 1,771.24%1.24M | 6,877.56%657.23K |
| Net increase in cash and cash equivalents | -1,355.16%-2.03B | -830.02%-1.01B | -179.41%-425.43M | 1.54%215.19M | 159.20%162.1M | 135.80%138.67M | 259.56%535.71M | -71.53%211.93M | 6.18%-273.8M | -144.91%-387.39M |
| Add:Begin period cash and cash equivalents | 8.52%2.74B | 8.52%2.74B | 8.52%2.74B | 9.16%2.53B | 9.16%2.53B | 9.16%2.53B | 9.16%2.53B | 47.41%2.31B | 47.41%2.31B | 47.41%2.31B |
| End period cash equivalent | -73.71%706.92M | -35.11%1.73B | -24.36%2.32B | 8.52%2.74B | 31.75%2.69B | 38.30%2.67B | 24.30%3.06B | 9.16%2.53B | 59.64%2.04B | -20.78%1.93B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.